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 ABSTRACT 
 
Chronic kidney disease (CKD) in children is a complex condition with the risk of progression to 
end-stage renal disease (ESRD) requiring dialysis or renal transplantation. Children with CKD and 
pediatric renal transplant recipients face a variety of complications, such as side effects of the 
treatment and concerns about deterioration of graft function. Urinary tract infections (UTIs) are 
common complications that may harm renal function. In the general population lower urinary tract 
(LUT) dysfunction is a major risk factor for UTI, but less is known about LUT dysfunction in 
children with CKD or a renal transplant. The overall aim of this thesis was to evaluate LUT 
function in children with CKD before and after renal transplantation, and to study the role of LUT 
dysfunction in relation to UTIs. An additional aim was to gain knowledge about associations 
between LUT dysfunction and health related quality of life (HRQoL) in children with CKD before 
and after transplantation. 
All studies were cross-sectional and included 40 children with CKD stages 3–5 (Studies III and 
IV), 68 children with a renal transplant (Studies I and II), and 59 children (Study V) with CKD 
stage 3–5 (n=23), or with a renal transplant (n=36). The documents and investigations used to 
evaluate LUT function were bladder diaries/questionnaires, uroflowmetry, bladder ultrasound (for 
measuring post-void residual urine), and, in Study IV, cystometry. The glomerular filtration rate 
(GFR) was assessed by the renal clearance of inulin or iohexol, or estimated by the plasma level of 
cystatin C. The history of UTI was obtained by reviewing the medical records. Two 
questionnaires, the Kidscreen-27 and Disabkids-37, were used for self-ratings of HRQoL and the 
modified Symptom Inventory for assessing associated subjective symptoms (Study V). 
One or more signs of LUT dysfunction were found in 72.5% of children with CKD and in 72% of 
those with a renal transplant. Signs of LUT dysfunction were observed in all (100%) of the 
children with CKD along with underlying urological disorders and in 59% with non-urological 
disorders (p = 0.0074). Regarding LUT function in children with a renal transplant, no significant 
difference was found in groups with and without urinary tract malformations (74% vs. 71%, NS). 
In children with CKD, 47.5% had a bladder capacity larger than expected and the large bladder 
was often combined with reduced bladder sensation. A discontinuous urinary flow was found in 
20% and 15% had residual urine.  Corresponding figures in children with a renal transplant were 
26%, 50% (17.6%, with a tower pattern excluded), and 32%. UTIs were more common in children 
with CKD and signs of LUT dysfunction than in those without (55% vs. 0%, p = 0.0012). In 
children with a renal transplant, recurrent UTIs were equally common in children with and 
without LUT dysfunction (35% vs. 42%, NS). Recurrent UTIs were, however, associated with a 
faster deterioration of GFR than in those without UTIs (p = 0.02). Children with CKD or a renal 
transplant with or without signs of LUT dysfunction reported a similar HRQoL, except those with 
incontinence, who reported lower HRQoL. Girls and older children rated well-being lower, as did 
those with a renal transplant. The entire study population perceived poorer well-being than healthy 
children, but similar to those with chronic conditions other than CKD.    
In conclusion, LUT dysfunction is common in children with CKD stages 3–5 and pediatric renal 
transplant recipients, not only in children with urological disorders but also in those with non-
urological disorders.  Earlier UTIs and LUT dysfunction seem to correlate in children before, 
but not after a renal transplantation. The findings in this thesis contribute to our knowledge about 
LUT dysfunction in children with CKD stage 3–5 and pediatric renal transplant recipients, but 
also to our knowledge about the association between HRQoL and LUT dysfunction as well as 
possible impact of CKD status, sex and age. Further research is needed before general 
recommendations for possible interventions can be given.  
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1 INTRODUCTION 
The idea for this project originated from our experience with and concerns for the 
children with recurrent urinary tract infections (UTIs) after renal transplantation. Our 
impression was that graft function declines faster in children who suffered from 
recurrent UTIs than in those without UTIs.  
 
Although UTI is a common complication with a prevalence of approximately 25–50% 
in children after renal transplantation [1-3], the underlying pathogenesis is not yet 
fully understood. In otherwise healthy children, classical risk factors for UTIs are 
urinary tract malformations, such as vesicoureteral reflux (VUR) and obstructive 
uropathy, female gender and young age [4]. Consequently, these risk factors have also 
been evaluated in children with recurrent UTIs after renal transplantation, but with 
conflicting results [5]. However, children with a renal transplant differ from otherwise 
healthy children in an important aspect: they are treated with immunosuppressants. 
This treatment impairs the immunologic host defense mechanisms and increases the 
risk for various infections. The immunosuppression may therefore seem be an obvious 
risk factor candidate for recurrent UTIs. However, since other groups of patients with 
similar immunosuppressive treatment do not suffer from UTIs to the same extent [6], 
immunosuppression cannot fully explain the increased susceptibility to UTIs in renal 
transplant recipients.  
 
When we planned this project, general knowledge was increasing about the 
importance of functional lower urinary tract (LUT) dysfunction as a risk factor for 
UTI in otherwise healthy children, but little was known about the impact of LUT 
dysfunction in children after renal transplantation. Furthermore, except for in children 
with urinary tract malformations, little was known about LUT function in children 
with chronic kidney disease (CKD), both before and after renal transplantation. We 
therefore decided to try to broaden this knowledge, and that was the starting point for 
this thesis.  
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2 BACKGROUND 
 
2.1 CHRONIC KIDNEY DISEASE IN CHILDREN 
Children with CKD face a life-long condition with a number of co-existing 
complications including cardiovascular disease, neurocognitive delay, anemia, growth 
failure, nutritional impairment, and metabolic disturbances, as well as the burden of the 
disease [7]. Early detection of childhood CKD and its complications is of the utmost 
importance in the management and progress of the condition [8]. However, no or only 
few signs of CKD are noticeable in the earlier stages by the patient, family and health 
care professionals [7], thus delaying the diagnosis and treatment and influencing the 
outcome. The long-term survival of children with end-stage renal disease (ESRD) has 
improved over the last decades, but is still about 30 times lower than among healthy 
children. The cause of death is mainly cardiovascular disease and infection [9].  
  
2.1.1 Criteria and definitions of CKD 
CKD has been defined by the National Kidney Foundation’s Kidney Disease Outcomes 
Quality Initiative (NKF-K/DOQI) [10] as presence of kidney damage, with or without 
decreased glomerular filtration rate (GFR), for 3 months or longer or GFR less than 59 
ml/min/1.73m², with or without kidney damage, for 3 months or longer [7, 11]. Kidney 
damage is defined as structural or functional kidney abnormalities, for instance 
abnormal urinary sediment, albuminuria, electrolyte disorders or other tubular function 
abnormalities, histological abnormalities, structural abnormalities on imaging studies or 
a history of kidney transplantation.  
  
CKD is classified into five stages according to the level of renal function, i.e. GFR [12, 
13]. This classification indicates the severity of CKD with higher stages representing 
more severe renal impairment. Stages 1–3 represent normal to mild and moderate forms 
of reduced renal function, sometimes with no or few symptoms Associated 
complications become more evident in stages 4 and 5 with decline of renal function 
[12]. ESRD is a severe health condition requiring lifesaving renal replacement therapy, 
dialysis or renal transplantation [14].   
  
2.1.2 Prevalence and causes of CKD  
CKD is a rare health condition among children. Based on the Swedish prevalence study 
of Esbjörner et al. the prevalence of CKD, defined as GFR < 30 ml/min/1.73 m² body 
surface area, was 59 per million children under 16 years during 1986–1994. The 
corresponding ESRD annual incidence was 6.4 and the prevalence 38 [15]. 
Corresponding figures from the rest of the world can be exemplified by data from 
Belgium, where the prevalence of CKD 3–5 was 56 for children aged 0–19 years in 
2001–2005 [9, 16], from Italy where the prevalence of  CKD with GFR less than 75 
ml/min/1.73 m
2
 was 75 per million children aged 0-19 years in 2003 [17], and from the 
USA, where the annual incidence of ESRD today is approximately 15 per million 
children [7].   
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In approximately two thirds of cases, the underlying cause of childhood CKD is 
congenital disorders. These include malformations of the kidneys and urinary tract and 
hereditary kidney diseases. Renal hypo-/dysplasia, obstructive uropathies and posterior 
urethral valves are common congenital forms of malformations, and nephropathies such 
as juvenile nephronophthisis, autosomal recessive polycystic kidney disease, congenital 
nephrotic syndrome, etc., are hereditary disorders.  Acquired kidney diseases, such as 
glomerulonephritis, vascular nephropathies, and other kidney disorders, are present in 
approximately one third of cases and are more frequent in older children [7, 15].   
 
2.1.3 Clinical characteristics of CKD 
CKD in children does not usually exhibit manifest signs and symptoms in its earlier 
stages, which may explain why the disease often remains undetected until later stages 
[16]. As a consequence of the delayed CKD diagnosis, complications may have already 
occurred before the diagnosis is made. The progress of CKD in children is influenced by 
the underlying disease, the severity of the initial kidney damage, and the presence of 
associated risk factors [7, 9]. 
In both adult and pediatric CKD patients the most important risk factors for renal 
disease progression are hypertension and proteinuria. Other common CKD related 
complications in children, such as dyslipidemia, acidosis, hypervolemia, and anemia, are 
associated with an increased risk of cardiovascular disease [8]. Complications, such as 
malnutrition, poor growth, and delay in neurocognitive development, and CKD-
associated symptoms such as nausea, fatigue, sleep disturbances, skeletal pain and 
urinary incontinence, are all factors with negative consequences for the child’s health-
related quality of life (HRQoL) [8, 18]  
 
 
2.2 TREATMENT OF CKD IN CHILDREN 
Early identification of pediatric CKD is important for optimizing the child’s health 
outcomes and capacity for normal growth and development. The goals for the treatment 
are to correct reversible causes of the disease, to prevent and to delay progression of 
CKD and to minimize the impact of CKD-related complications [7, 19, 20]. 
Furthermore, since childhood CKD is a lifelong condition, children and their caregivers 
need to be carefully informed about and aware of the progressive nature of the disease 
and the possible future need for dialysis or transplantation [19].    
 
Management of CKD throughout its different stages often involves careful monitoring, 
pharmacological interventions, and dietary restrictions. The child may need repeated 
surgical procedures, such as vascular accesses, peritoneal catheters, gastrostomies, etc. 
Initiating an effective management of hypertension and proteinuria is beneficial already 
in early CKD stages [21]. Other important therapeutic interventions are correction of 
anemia, metabolic acidosis, and renal osteodystrophy, which are some of the factors 
leading to malnutrition and poor growth. In addition to early nutritional interventions, 
these children may need growth hormone therapy to optimize growth and, in the long 
term, improve psychosocial development and the quality of life (QoL) [8, 12].  
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2.2.1 Dialysis modalities 
To manage ESRD, renal replacement therapy with peritoneal dialysis (PD), 
hemodialysis (HD) or kidney transplantation remains the treatments of choice. For 
children with ESRD, transplantation is considered to provide the best long-term survival 
and quality of life [22, 23]. However, preemptive transplantation, i.e., transplantation 
without previous dialysis, is not always possible and depends on the availability of a 
living or deceased graft donor. Dialysis is often necessary for a period of time for most 
children with ESRD [22]. The choice of dialysis modality is based on such factors as 
patient age, lifestyle factors, family prerequisites and availability of facilities and 
expertise at the pediatric unit [24, 25]. PD is the preferred modality in pediatric ESRD 
patients, especially in younger children, because the treatment can be performed at home 
by the parents and allows as much ”normality” as possible [22, 23]. For instance, the 
child can often attend school as usual. An additional advantage of PD is preservation of 
residual renal function compared to HD [24]. 
Hemodialysis is performed three to five times a week at the hospital and may be 
considered, if PD is not possible to perform, if the parental support is poor, or if HD is 
preferred by the child (in these cases often a teenager). Reasons for not being able to 
perform PD are for instance a history of complicated abdominal surgery, recurrent 
episodes of peritonitis, or inadequate dialysis with PD [24]. 
  
2.2.2 Kidney transplantation 
Kidney transplantation (Tx) has been the preferable treatment goal for children with 
ESRD during recent decades. Patient and graft survival outcomes have improved 
substantially due to experience gained over time, better surgical techniques, and refined 
immunosuppressive regimens, especially the introduction of calcineurin inhibitors. 
Nowadays, renal transplantation is regarded as a safe and effective treatment for patients 
who previously were not considered suitable for transplantation, for example, very 
young children and children with systemic or metabolic diseases [26, 27]. Furthermore, 
children with urological diseases and LUT dysfunction are often accepted, provided that 
LUT dysfunction is properly managed before transplantation [28-30].   
  
Data from the North American Pediatric Renal Trials and Cooperative Studies 
(NAPRTCS) [31] report increasing short- and long-term graft survival, as well as 
decreasing acute rejection rates. The American five-year graft survival rate was 86.5% 
for living donor (LD) recipients in the period 1987–2010, which is higher than the graft 
survival rate of 83.2% for deceased donor (DD) recipients [32]. In Europe, the 
corresponding figures for the period of 2003–2007 are 96.8% for LD and 95.3% for DD 
recipients [33]. Possible causes for this discrepancy in survival rates may be a higher 
proportion of living donor transplantations in Europe, socio-economic factors, access to 
health care and insurance matters.  
   
Compared to dialysis, renal transplantation is associated with improved survival, better 
growth, and better cognitive development [25, 34]. Efforts have been made to increase 
access to transplantation for children and adolescents by changing deceased donor 
allograft policies as well as by developing methods to diminish donor-specific anti-HLA 
antigen antibodies [25, 26]. Despite the encouraging patient and graft survival rates in 
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children, there are still unsatisfied demands concerning post-transplant care [26]. To find 
strategies to optimize growth and cognitive development in these children is of great 
importance. Factors such as an increased risk for cardiovascular diseases, infections, and 
malignancy can compromise short- and long-term outcomes, thus focused efforts are 
required to prevent these complications [27, 32]. Adolescent kidney transplant recipients 
do not have as good survival rates as recipients under 10 years of age, especially in the 
long term [26]. This is mainly due to factors related to physical side effects of the 
immunosuppressive medication and subsequent non-adherence. In addition to age, 
transition to emotional independence in this period of life entails a risk of non-adherence 
[26]. Also other risk factors for non-adherence have been identified: socio-economic 
issues and low self-awareness due to poor cognitive abilities, as well as parental stress 
and disturbances in parent-child interactions [34]. Continued efforts to minimize 
complications and to optimize growth, neurodevelopment, and the HRQoL in children 
after transplantation are required [26, 34, 35].  
 
All children considered for renal transplantation undergo a thorough pre-transplant 
evaluation in order to avoid post-transplant complications and optimize the outcome 
[27]. The content of such an evaluation may differ from one center to another, but it 
usually includes comprehensive laboratory, physiological, and imaging studies, 
exploring, among other things, CNS, lung, cardiovascular, and liver function. A 
urological evaluation including voiding cystourethrogram and urodynamic studies is of 
particular importance in children with congenital abnormalities of the kidneys and the 
urinary tract [27, 36, 37] and is often restricted to this group of patients. A psychosocial 
evaluation including risk factors for non-adherence is not to be overlooked in the pre-
transplant evaluation process in order to be able to identify the need for interventions 
[27]. 
 
  
2.3 THE LOWER URINARY TRACT  
The urinary tract consists of the upper urinary tract, i.e., the kidneys and ureters, and the 
LUT, i.e., the bladder, the urethra, and the sphincter system (Figure 1). In healthy 
individuals the kidneys produce urine continuously passing through the two ureters to 
the bladder for low-pressure storage until eliminated through the urethra. Several 
mechanisms prevent retrograde flow of urine to the upper urinary tract.  
 
Figure 1. The upper and lower urinary tract. 
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2.3.1 Storage and emptying function   
The urinary bladder has two main functions, the first is to serve as a reliable reservoir 
and the second is to empty the urine completely without any difficulties such as pressing 
or straining. Important requirements of the bladder are high compliance during bladder 
filling and the ability to generate adequate pressure to empty the bladder. In order to 
meet these demands, the urinary bladder is a highly expandable muscular sac in which 
the fibers of the main smooth muscle component, the detrusor, are arranged in spiral, 
longitudinal, and circular bundles [38]. The storage and emptying functions are 
controlled by a complexity of neurological interactions involving the central nervous 
system (CNS) and three sets of peripheral nerves: parasympathetic, sympathetic, and 
somatic nerves [38]. A proper “on-off”-like coordination between these components is 
essential for either maintaining continence or inducing micturition [39].   
 
2.3.2 Micturition physiology in childhood 
Maturation of the CNS as well as adequate social prerequisites is required for the 
development of voluntary bladder control. Higher CNS centers are already involved in 
micturition in newborns and the infant usually wakes up, at least for a short while, as the 
micturition occurs. Incomplete voiding during the first years of life is common owing to 
immature detrusor-sphincter coordination but disappears when voluntary bladder control 
is achieved [40], often the age of 5–6 years [41]. Bladder capacity and voided volumes 
increase gradually during toilet training allowing the child to hold the urine voluntarily. 
Voiding frequency is related to age and decreases from approximately once per hour in 
the infancy period [42] to 7–8 times per day in toddler years [43]. Most school-aged 
children (7 to 15 years old) void between 3 and 8 times per day [44]. Recent studies 
have shown that voiding control can be trained earlier than practiced nowadays in 
Western cultures. Toilet training before the first year of life has proved to facilitate a 
complete bladder emptying, thus, possibly to benefit those children with LUT 
abnormalities [45].        
 
2.3.3 LUT function – terminology  
The International Children’s Continence Society (ICCS) provides guidelines on 
terminology and pediatric LUT evaluation in children [46, 47]. The guidelines describe 
different manifestations of LUT function and dysfunction aiming at facilitating 
understanding and communication between those who take care of children and 
adolescents with LUT dysfunction. The guidelines have recently been updated [48]. 
 
2.3.3.1. Definitions considering storage and voiding symptoms according to the ICCS 
guidelines [47, 48] 
 
A voiding frequency of 3 to 7 voids daily is suggested to be normal for 7-year-olds, but 
it is influenced by diuresis and fluid intake. 
Urinary incontinence means repeatedly occurring involuntary leakage of urine in 
children of at least 5 years of age. Incontinence is further divided into the categories 
continuous and intermittent incontinence, and daytime incontinence or enuresis.  
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Urgency refers to a sudden and unexpected need to void, and is often regarded as a sign 
of bladder overactivity. 
Nocturia applies to children of at least 5 years of age who wake up at night to void. This 
symptom does not necessarily indicate LUT malfunction.   
Hesitancy signifies difficulty in initiating voiding although the child is ready to void. 
Straining implies an effort to increase intra-abdominal pressure to initiate and maintain 
voiding. 
Weak stream is an observed urinary stream or uroflow of weak intensity.  
Intermittency indicates micturition with several stop and start spurts. However, this is 
physiological up to the age of 3 years if straining is not present.    
 
2.3.3.2. Voided volume, expected bladder capacity, and polyuria according to the ICCS 
guidelines [47, 48] 
  
Voided volume characterizes the volume of urine measured at micturition and recorded 
in the voiding diary. The maximum voided volume (MVV) refers to the largest volume 
measured throughout a 24-hour cycle. 
Expected bladder capacity (EBC) is defined according to the formula: 30 + (30 x age in 
years) ml and is applicable to children between aged 4–12 years. The MVV (obtained 
from bladder diary) is defined as small if found to be less than 65%, or as large if greater 
than 150% of the EBC. 
Polyuria is considered to occur when the urine output exceeds 2,000 ml/m² body surface 
area.  
 
2.3.4 Common functional LUT disturbances in children 
The most common functional LUT disturbances in children without neurological or 
structural disorders are enuresis and daytime incontinence. The prevalence of enuresis 
and daytime incontinence is 5–10% in 7-year-old children [49, 50]. Daytime 
incontinence is often caused by detrusor overactivity [43] and is more common in girls 
who usually experience concomitant urgency symptoms. This condition tends to give 
rice to such as postponing micturition as long as possible using various “holding 
maneuvers”, e.g., squatting with the heel against the perineum. Constipation with or 
without fecal incontinence is common in these children and may play an important role 
in LUT dysfunction [51]. The same group of children may have incomplete voids with 
residual urine and is subsequently at higher risk of developing UTI [52]. The cause of 
detrusor overactivity is debated but it may originate from a mild delay in the maturation 
of the CNS which interferes with the ability to gain voluntary control over the 
micturition reflex [43, 52].  
Enuresis occurs more often in boys and may be combined with daytime incontinence or 
urgency symptoms. Pathogenetic factors of importance are difficulty to wake up in 
response to activation of the micturition reflex, nocturnal polyuria, and/or inability to 
manage detrusor contractions [43].    
Daytime incontinence and enuresis are known to have a negative impact on self-esteem 
and HRQoL in the affected children [53]. However, since self-esteem has been shown to 
become normalized after a successful treatment, it is important to offer treatment as 
soon as the child is motivated [54, 55].   
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2.4 URINARY TRACT ANOMALIES IN CHILDREN   
In contrast to adults, about 35% of children with CKD in its advanced stages have 
underlying urological anomalies [56]. In adult patients with ESRD, congenital 
anomalies of the kidney and urinary tract account for less than 5%, with diabetic and 
non-diabetic glomerulopathies dominating the disease spectrum [9, 57].   
 
Common congenital urological disorders include posterior urethral valve (PUV), vesico-
ureteric junction (VUJ) and pelvi-ureteric junction (PUJ) obstruction, VUR, neuropathic 
bladder, and prune belly syndrome. Acquired urological disorders include renal tract 
stones, urethral strictures, neuropathic bladder, and tumors [58].  
 
LUT abnormalities can have a devastating effect on renal function [56]. If unsolved, the 
ongoing urinary output in combination with urinary tract obstruction causes an increased 
pressure which dilates the collecting system proximal to the obstruction. The elevated 
pressure in turn damages the tubules, which leads to a decreased urine-concentrating 
ability and, consequently, polyuria. Polyuria may in turn lead to chronic bladder over-
distension, bladder wall thickening, loss of compliance, secondary detrusor over-activity 
and subsequent problems involving incontinence and enuresis [56]. The impaired 
drainage of the urine from the upper urinary tract also imposes a risk for VUR, 
hydronephrosis, UTI, and renal damage [28, 56]. The injury to the glomeruli is often 
secondary to the processes mentioned above, but regardless of the cause, it leads to a 
reduced glomerular filtration rate (GFR) and progressive CKD [58]. 
 
Urological disorders in children often lead to voiding disturbances, which occurs for 
example in boys with PUV. Other underlying urological causes that affect bladder 
function are neuropathic bladder secondary to spinal abnormalities, VUR, and prune 
belly syndrome [28]. 
 
Children with CKD due to non-urological disorders may also suffer from polyuria. 
Many hereditary disorders affect tubular function and the ability to concentrate the 
urine. Even if not combined with an outflow obstruction, polyuria is associated with a 
risk of developing a large capacity bladder with impaired sensation of distension or 
over-distension with an underactive bladder as the clinical endpoint [59]. Severe 
oliguria or anuria is common in children on long-term dialysis and is associated with 
an increased risk of developing a small, defunctionalized, poorly compliant, high-
pressure bladder, and subsequent upper urinary tract damage [56, 60]. 
 
LUT function in children with CKD due to other causes than urological ones is not a 
well-studied subject area. However, a large capacity bladder, emptying problems and 
incontinence, possibly indicating LUT dysfunction, were reported by Van der Weide 
et al. to be common also in children with CKD of non-urological origin [59].   
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2.5 THE LUT FUNCTION AND UTI 
Several mechanisms are important in the host defense against UTIs, for instance, the 
interaction between normal bacterial flora and potential pathogens, desquamation of 
epithelial cells with adhering bacteria, local production of antibacterial peptides and 
other immunological mechanisms [61]. The most important defense mechanism is, 
however, a regular and complete emptying of urine from the bladder and the urinary 
tract. This will prevent bacteria from colonizing the bladder and invading the upper 
urinary tract [62]. In children with structural or functional LUT abnormalities, this 
most important defense mechanism is disturbed [61, 63, 64].  
 
In the pre-antibiotic era children who did not die from their UTIs often recovered with 
substantial renal damage as a sequel of the infection [61]. Important research revealed 
the association between UTIs, vesicoureteral reflux (VUR), and renal damage [65, 66], 
and therefore much effort was concentrated on finding out how to deal with VUR. 
Further research showed that renal damage could be prevented equally well by either 
antibacterial prophylaxis or by anti-reflux operations [67]. However, in a substantial 
number of children who experienced recurrent UTIs and renal damage, no VUR was 
detected [64]. These children often suffered from incontinence and other signs 
consistent with LUT dysfunction, a condition that later proved to be another major risk 
factor for recurrent UTIs [63, 64]. 
 
  
2.6 EVALUATION OF LUT FUNCTION IN CHILDREN 
A comprehensive history and physical examination are the cornerstone tools in the 
diagnostic evaluation of children and adolescents with LUT dysfunction. Further 
diagnostic tools are categorized into invasive and non-invasive urodynamics. 
  
2.6.1 Non-invasive urodynamic investigations 
A bladder diary consists of a 48-hour frequency and volume chart and is used to obtain 
information about such parameters as voided volumes, voided frequency, urinary 
outputs, fluid intake, and associated symptoms [47, 68]. Different scoring systems and 
questionnaires have been developed for measuring LUT dysfunction and the emotional 
impact of urinary incontinence [69-72]. However, few of them have been cross-
culturally validated and tested for reliability. 
 
Uroflowmetry measures the flow rate, the voided volume, and the voiding time during 
urination. The voiding pattern is presented as a uroflow curve. Five different curve 
shapes occur: bell-shaped, tower-shaped, staccato-shaped, interrupted-shaped, and 
plateau-shaped (see “Material and Methods”). These curve shapes may serve as guides 
to the underlying pathology [51]. Repeated measurements are required to confirm 
suspected dysfunctional voiding [48, 73]. Uroflowmetry may be combined with 
electromyography (EMG) to measure the pelvic floor muscle activity during voiding 
[74]. 
 
As mentioned earlier, a child should empty the bladder completely. Assessment of post-
void residual urine is therefore an important diagnostic tool and the assessment should 
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be performed within a maximum of five minutes after completing the uroflow 
measurement. Real-time equipment is preferred for diagnostic use. Post-void residual 
urine exceeding 20 ml at repeated measurements indicates incomplete bladder emptying 
[47].   
 
The bladder diary, uroflowmetry, and residual urine measurements may be referred to as 
“urodynamic screening”. 
 
2.6.2 Invasive urodynamic investigations: Cystometry 
Invasive urodynamic studies (cystometry and pressure flow studies) are not routinely 
performed to evaluate LUT function in children but have a given place in the evaluation 
of LUT function in children with neurogenic bladder, structural anomalies of LUT, 
and/or functional voiding problems resistant to treatment [51, 52]. Since the 
investigation is known to be associated with psychological distress due to the 
transurethral or suprapubic catheterization, it is important to reduce child and parental 
distress by an adequate preparation prior to the procedure, and additionally, thereby also 
ensure a safe and reliable examination [48, 75, 76]. A non-invasive evaluation allows us 
to identify children who will benefit from invasive urodynamics [77, 78]. Cystometry is 
used to record urodynamic conditions during the filling phase of the micturition cycle. 
Bladder sensation, detrusor activity, bladder compliance, and bladder capacity are 
parameters concerning the obtained bladder storage function and serve as important 
markers to identify children at risk for upper urinary tract damage [52, 77, 79].   
 
 
2.7 MANAGEMENT OF LUT DYSFUNCTION 
The primary goal of treatment of LUT dysfunction is to normalize bladder function and 
to prevent kidney injury. Surgical interventions may be required as treatment for 
children with structural or neurogenic LUT anomalies. 
  
The first-line treatment for children with various LUT disturbances is bladder 
rehabilitation. This treatment model is based on cognitive behavioral principles and 
includes such components as providing knowledge about normal LUT and bowel 
function and which behavioral changes are needed to correct the voiding habits. The 
child is given instructions about timed voiding in order to train the voluntary central 
nervous control of the micturition [80]. Training of a relaxed voiding posture is basic 
and can be administered by means of instructions and simple exercises to gain 
awareness of the relaxed or contracted pelvic floor muscles [81, 82]. Regular follow-up 
visits to repeat the instruction and increase understanding and motivation give  valuable 
and encouraging support [80]. 
 
Voiding school was developed by Glad Mattsson et al. as an alternative to the individual 
treatment model [83]. This form is applicable for children in small groups and has 
shown positive results with regard to reducing UTIs and incontinence. More specific 
urotherapeutic nonmedical interventions used include different forms of biofeedback 
training, electrical stimulation, and clean intermittent catheterization (CIC) [84]. 
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Children with anatomical LUT abnormalities, such as obstructive uropathy or a severe 
VUR, may need surgical corrections, often primarily, to relief the obstruction or 
facilitate urine drainage from the upper urinary tract. Older children with neurogenic 
bladder sometimes require enlargement of the bladder or other reconstruction 
procedures to improve bladder compliance [56]. 
 
Management of LUT dysfunction, when the causes are other than functional 
disturbances, may require additional interventions to achieve acceptable storage and 
emptying function. Frequent voids and double micturition are useful methods to 
optimize bladder emptying in children with post-void residual urine [56]. 
Anticholinergic medication is used as a complement to improve storage by relaxing the 
detrusor muscle and increasing compliance. Polyuria in children as well as infrequent 
voiding habits should be addressed in order to prevent bladder distension. Overnight 
catheter drainage has been reported to be an effective therapy in children with severe 
polyuria in order to prevent chronic bladder distension and kidney function deterioration 
[52, 56, 85]. 
 
CIC has become a safe and effective treatment option for children with severe bladder 
emptying problems of various etiologies [52]. CIC is the treatment of choice in children 
with neurogenic bladder dysfunction for minimizing the consequences of detrusor 
sphincter dyssynergia [52, 56]. Early treatment with CIC not only reduces the risk for 
UTIs and kidney damage but also helps to enhance urinary continence in these children 
[86, 87].  
 
 
2.8 HRQOL  
Over the last few decades, medical, surgical, and immunological advances have 
dramatically improved treatment outcomes and long-term survival rates for children 
with CKD or a kidney transplant [14, 26]. However, optimal care of pediatric renal  
patients should aim not only at excellent survival rates, but also at attention to how the 
children feel and get along with everyday life [88]. In this context, HRQoL has become 
an important health indicator for treatment outcome as well as measure of the impact of 
the condition in people suffering from various diseases, including children with CKD at 
different stages [88-90].  
 
Definition of HRQoL 
QoL is often used synonymously with HRQoL but is a general concept lacking 
consensus on a clear definition. QoL includes a broader range of aspects, e.g., 
environmental and economic issues, and can adapt different meanings to different 
individuals depending on the context [91]. The term has traditionally referred to health 
status, physical functioning, symptoms, psychosocial adjustment, well-being, life 
satisfaction, and happiness [92]. In the context of medical outcomes, QoL has a clear 
connection to subjective and objective health and disease and treatment-related well-
being [93]. Health, as defined by the World Health Organization (WHO) [94] as -“a 
state of complete physical, mental and social well-being, and not merely the absence of 
disease”-, is an important component of quality of life [95].  
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HRQoL is a part of the broader concept of QoL. A variety of definitions and models 
across different health and illness conditions have been used to explain the concept 
HRQoL [96]. HRQoL is related to one’s health and described as a “multidimensional 
concept covering physical, mental, social and behavioral components of well-being and 
function as perceived by patients and/or other observers” [93, 95, 96]. This latter 
definition of HRQoL agrees with the one used in this thesis. 
     
2.8.1 Measure of HRQoL in children 
Measuring HRQoL in children and adolescents encounters unique demands, compared 
to measuring in adults [89]. A meaningful development of a QoL instrument requires 
consideration of age-related issues, as well as maturity and cognitive development [93]. 
Another question has been how to get reliable answers from children. Agreement 
between child and parent ratings concerning the child’s HRQoL has also been 
questioned. The child ratings are, however, preferable whenever possible even though 
HRQoL ratings obtained from a parent or caregiver may serve as an additional source of 
information [93, 97]. 
 
The development of appropriate instruments for measuring HRQoL in both healthy and 
chronically ill children has been encouraging, a number of them fulfilling requirements 
of age and cognitive appropriateness [89]. Generally, HRQoL measures can be divided 
into two main categories: generic and disease-specific measures [89, 91]. Generic 
questionnaires address issues not directly related to disease and can provide information 
from healthy children as well as children with different diseases or conditions. This 
allows comparisons across different groups and for comparisons with the general 
population. The criticism of generic instruments is that they may fail to capture 
information of particular concern in certain groups [91]. Disease-specific instruments 
may be useable for detecting important clinical information. Their limitation is, 
however, that a comparison of HRQoL measurements with those in other illness groups 
is not possible [93]. Generic measures with disease-specific modules are also available; 
an example being the widely used PedsQoL [98]. The European 
KIDSCREEN/DISABKIDS project has developed similar instruments for measure of 
generic, chronic illness generic and condition-specific (disease-specific) aspects of 
HRQoL [90, 99-101].  
 
In this thesis, two questionnaires, one generic and one chronic generic, were used to 
measure the HRQoL. The Kidscreen-27 and the Disabkids Chronic Generic Module-37 
(DCGM-37) instruments were chosen because they were developed in Europe and 
provide a European reference material. The two instruments allow assessment of generic 
and chronic illness generic aspects of HRQoL in children and adolescents and are usable 
in health research and clinical settings in different cultures [90]. The European 
KIDSCREEN and DISABKIDS projects developed the instruments in a cross-cultural 
approach, were in close collaboration with each other and used the same methodology. 
The developmental process included literature research, expert panels and focus groups 
with children in order to identify items and dimensions, and then finally field testing and 
pilot studies. The same methodological approach allows combining of both measures 
[90].  
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2.8.2 HRQoL in children with CKD or a kidney transplant  
HRQoL in children and adolescents with CKD with a focus on different stages of CKD 
and different treatment modalities has been studied only sparsely. A few studies have 
evaluated HRQoL before the children has reached ESRD [12]. Gerson et al. [102] have 
described HRQoL in children with mild to moderate CKD and reported impairments in  
physical, school, emotional, and social functioning, as well as poorer overall HRQoL 
compared to the general population. Furthermore, anemia, short stature, and shorter 
disease duration were found to be variables predicting HRQoL impairments [102-104]. 
Gerson et al. reported that HRQoL was already affected in the early stages of CKD, but 
did not deteriorate between stages 1 and 3 [102]. Other researchers have studied children 
with CKD in advanced stages (stage 4 and 5) and reported reduced physical and 
psychosocial functioning in comparison with healthy children [105-107].  
 
The CKiD (Chronic Kidney Disease in Children) Study identified important factors 
associated with a negative influence on HRQoL. Short stature (<5
th
 percentile for 
height), sleep disturbances, fatigue, and urinary incontinence were found to be common 
conditions affecting HRQoL [102, 108-110]. The authors pointed out the importance of 
detecting and providing treatment for these problems. 
 
Children and adolescents with ESRD have reported a variety of problems such as an 
impaired sense of self-worth, uncertainty about the future, and limitations in physical 
and psychosocial capacities [111], and children receiving long-term dialysis have been 
shown to have even lower overall health and well-being than those treated for newly 
diagnosed cancer [112]. Optimizing the care of children and adolescents with ESRD 
regularly and standardized assessments of HRQoL are necessary to identify areas where 
support is required [25, 113].  
 
Kidney transplantation is a successful therapy with excellent outcomes in pediatric 
patients [114]. A number of reports have indicated better HRQoL in pediatric renal 
recipients than in those receiving dialysis [112, 114-116]. There are, however, 
conflicting results with other authors reporting no differences in most of HRQoL 
domains in children on dialysis as opposed to those with a renal transplant [106, 117, 
118]. Several studies have pointed out factors which may have a negative influence on 
HRQoL in pediatric renal recipients. Neurodevelopmental delays and cognitive 
impairments interfering with psychosocial adjustment are some of them [119]. 
Impairments in physical functioning and exercise capacity contribute to diminished 
well-being [120]. Medication-related negative effects such as weight gain, headache and 
fatigue are other common factors affecting several domains of HRQoL and thus are 
important to pay attention to in pediatric renal recipients [104, 116, 119, 121-123].  
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3 AIMS OF THE STUDIES 
The overall aim of this thesis was to evaluate LUT function in children with CKD 
before and after renal transplantation and to study the role of LUT dysfunction in 
relation to UTIs. An additional aim was to study potential associations between LUT 
dysfunction and HRQoL in these children. 
 
Specific aims were: 
 
Study I: To evaluate the prevalence and type of LUT dysfunction in children after 
kidney transplantation, and to evaluate whether LUT is more common in certain disease 
groups compared to others.  
 
Study II: To evaluate the association between LUT dysfunction and UTI in children 
after kidney transplantation and to study the impact of recurrent UTIs on graft function. 
 
Study III: To evaluate the prevalence and type of LUT dysfunction in children with 
CKD, to evaluate whether LUT dysfunction is more common in certain disease groups 
and, furthermore, to evaluate the association between UTIs and LUT dysfunction in 
these children. 
 
Study IV: To further define LUT function with cystometry in children with CKD and 
LUT dysfunction according to non-invasive urodynamics. Additionally, to explore what 
information invasive urodynamics (cystometry) can add to the non-invasive technique in 
order to find out which children will benefit from this investigation in pre-transplant 
evaluations. 
 
Study V:  To evaluate potential associations between LUT dysfunction and HRQoL in 
children with CKD (with or without a renal transplant) and, further, to evaluate 
associations in relation to children with other chronic conditions and to those in the 
general population.   
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4 MATERIALS AND METHODS 
 
4.1 STUDY DESIGN AND PARTICIPANTS 
The participants in all of the five studies presented here were children and adolescents 
treated at the Pediatric Nephrology Unit at Astrid Lindgren Children’s Hospital in 
Stockholm, which is a referral center for children with kidney diseases in Sweden. The 
center treats children from the middle and northern parts of Sweden (covering 
approximately two thirds of the pediatric population). The design was cross-sectional, 
descriptive, and comparative. Studies II and III were partly retrospective. An overview 
of the studies is presented in Table 1.  
 
  
Table 1. Overview of the design and patient characteristics in each study 
 
Study I II III IV V 
Design Cross-sectional 
Comparative 
Cross-sectional 
Retrospective 
Cross-sectional 
Comparative 
Retrospective 
Cross-sectional  
Comparative 
Descriptive 
Retrospective 
Cross-sectional 
Comparative 
Descriptive  
Participants 68 Same group as in 
Study I 
40 17 
A subgroup of 
Study III 
59 
Male/Female 37/31   27/13 14/3 30/29 
Age range 5–20   5–18 6–18 8–19 
CKD, stage 3-5   40 17 23 
Tx 68    36 
Urological 
disorders 
Males 
 
23 (34%) 
16 
  
13 (32.5%) 
11 
 
11 (65%) 
9 
 
19 (32%) 
12 
Non-urological 
disorders 
Males 
 
45 (66%) 
21 
  
27 (67.5%) 
16 
 
6 (35%) 
5 
 
40 (68%) 
18 
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4.1.1 Study I 
Studies I and II are based on the same population. Inclusion criteria were children 
referred to the clinic, aged 5 years or older, without a urinary diversion. Between 2002 
and 2003, 73 children underwent their yearly follow-up examination after renal 
transplantation, including a renal function investigation (glomerular filtration rate, 
GFR). Of these children, 68 completed the routine control of bladder function including 
a questionnaire, uroflowmetry, and bladder ultrasound. The children were 5–20 (median 
14.3) years old at examination, and the median time from kidney transplantation was 5 
(range, 1–15) years. Causes for not participating (5 children) were other commitments 
(2), lack of time (2), and inability to perform uroflow measurements due to mental 
retardation (1). 
 
4.1.2 Study II 
The same population as in study I. The patients’ medical records were retrospectively 
reviewed regarding UTI history (number and timing) and earlier graft function (GFR). 
Additionally, parents were questioned about their child’s UTI history. UTIs within the 
first month after transplantation were excluded because of the known association with 
surgery-related matters (indwelling catheters, injury to the mucocutaneous surfaces and 
graft, etc.).  
 
4.1.3 Study III 
Between 2006 and 2008, a total of 40 children with moderate to severe CKD (GFR 
range 5–50 ml/min/1.73 m²), age 5–18 (median 11.5 years), and with bladder control 
and sufficient developmental maturity to understand the instructions, underwent their 
yearly check-up including an evaluation of renal and lower urinary tract function. All 40 
children consented to participate in the study. Children younger than 5 years old without 
bladder control, those with urinary tract diversions, and those without sufficient 
cognitive ability to cooperate in the investigations were not approached. 
 
4.1.4 Study IV 
In the cohort of the 40 children in Study III, 29 were identified as having suspected 
bladder dysfunction based on the reported symptoms and abnormal findings from the 
bladder diary, uroflowmetry, or bladder ultrasound. These children were recommended 
invasive urodynamics (cystometry) to further explore their bladder function. Four of the 
children received a kidney transplant before investigation, 6 refused to participate, and 2 
were lost to follow-up (transferred to adult care). Seventeen children, aged 6–18 years, 
accepted and consented to a cystometric investigation.  
 
4.1.5 Study V 
A sample of 64 eligible children, i.e. those over 8 years old, with CKD stage 3 to 5, or 
with a kidney transplant and with developmental maturity, was approached during 
2011–2012 in the same setting as previously. Three declined due to lack of time (1) and 
simple refusal (2) and two children were excluded due to incomplete investigations, 
finally leaving 59 participants aged 8–19. A healthy comparison group of children, 
randomly selected from the Swedish population registry, SPAR, comprising 257 
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subjects (response rate 54%), aged 11–23 was recruited and asked to answer the QoL 
questionnaire, Kidscreen-27 [124]. In order to age-match our study group, only 
participants under 19 years old, a total of 203, were included as one of the comparison 
groups in the present study. To compare data obtained from the DCGM-37 
questionnaires, the results from field studies comprising 1152 children, aged 8–16 years 
and with different chronic conditions [99, 125], were used as a reference for our data.  
 
The number of children included in the studies and their overlapping is outlined in 
Figure 2.   
 
 
 
 
Figure 2. Overview of participants in Studies I-V and their overlapping.  
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4.2  UNDERLYING DISEASES IN STUDIES I-V  
An overview of the causes of CKD or ESRD is outlined in Table 2. Diseases are 
grouped as congenital diseases with (UTM+) and without urinary tract malformations 
(UTM-) and acquired diseases.    
 
Table 2. Overview of diagnoses in children with CKD or a renal transplant. 
 
Diagnoses Study I, II Study III Study IV Study V 
  N = 68 N = 40 N = 17 N = 59 
C
o
n
g
en
it
al
 d
is
o
rd
er
s 
+
 U
T
M
 
U
ro
lo
g
ic
al
 d
is
o
rd
er
s 
PUV 
Drash syndrome 
Prune belly 
Meatal stenosis 
VUR ± dysplasia 
Neurogenic bladder 
Other urinary tract anomalies 
8 (12%) 
2 (3%) 
4 (6%) 
1 (1.5%) 
 
 
5 (12.5%) 
 
 
 
7 (17.5%) 
1 (2.5%) 
5 (29%) 
 
 
 
5 (29%) 
1 (5.9%) 
5 (8.5%) 
 
 
 
10 (17%) 
1 (1.7%) 
3 (5.1) 
 
 
C
o
n
g
en
it
al
 d
is
o
rd
er
s 
-U
T
M
 
N
o
n
-u
ro
lo
g
ic
al
 d
is
o
rd
er
s 
Nephronophthisis 
Polycystic kidney disease 
Congenital nephrotic syndrome 
Jeunes syndrome 
Braun-Bayer syndrome 
Branchio-oto-renal syndrome 
Hypoplasia/dysplasia* 
Metabolic disease 
Oligomeganephronia 
 
10 (15%) 
3 (4.5%) 
8 (12%) 
1 (1.5%) 
1 (1.5%) 
1 (1.5%) 
8 (12%) 
 
4 (10%) 
4 (10%) 
1 (2.5%) 
 
 
 
5 (12.5%) 
2 (5%) 
1 (2.5%) 
1 (5.9%) 
 
 
 
 
 
3 (17.6%) 
1 (5.9%) 
1 (5.9%) 
 
5 (8.5%) 
3 (5.1%) 
6 (10.2%) 
 
 
 
7 (11.9%) 
1 (1.7%) 
1 (1.7%) 
 
A
cq
u
ir
ed
 
Neonatal ischemia 
Glomerulonephritis 
Wegener’s granulomatosis 
Atypical hemolytic uremic       
syndrome (aHUS) 
Focal segmental 
glomerulosclerosis (FSGS) 
Nephrogenic diabetes insipidus 
Interstitial nephritis  
5 (1.25%) 
10 (15%) 
1 (1.5%) 
 
1 (1.5%) 
 
3 (3%) 
1 (1.5%) 
 
 
1 (2.5%) 
3 (7.5%) 
 
 
2 (5%) 
 
 
 
2 (5%) 
 4 (6.8%) 
5 (8.5%) 
 
 
2 (3.9%) 
 
3 (5.1%) 
  CKD of unknown cause  2 (5%)  3 (5.1%) 
 
* In Study I classified as Congenital disorders + UTM 
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4.3 DEFINITIONS 
4.3.1 CKD 
CKD is classified into different severity levels (stages 1–5) according to the “Kidney 
Disease: Improving Global Outcomes” (KDIGO) clinical practice guidelines (2012) 
[11]. Moderate to severe stages of CKD and ESRD (stages 3 to 5) correspond to GFR 59 
ml/min/1.73 m² or lower. Children with a renal transplant are sometimes referred to as 
having CKD-T (CKD transplant) as they have in fact a chronic kidney disease even 
though it is treated with a renal transplant. In most cases, renal function improves 
significantly after renal transplantation and a GFR of approximately 70–80 ml/min/1.73 
m
2
 is not uncommon at the first annual post-transplant control. Due to rejections, 
infections, toxic effects of the medication, and other complications, graft function often 
gradually declines over time, however, and the patient again reaches different levels of 
CKD according to the above-mentioned definitions. In this thesis, children with CKD 
stage 3–5, i.e., GFR 59 ml/min/1.73 m² or below were referred to as children with CKD; 
pediatric renal transplant recipients with different stages of CKD were referred to as 
children with a renal transplant or pediatric transplant recipients.   
 
4.3.2 LUT dysfunction / bladder dysfunction 
In this thesis, symptoms and conditions defining LUT function and dysfunction are 
according to the ICCS former guidelines [46, 47], i.e., the guidelines available when 
planning the studies. At the beginning of this project, entities within the concept of LUT 
dysfunction (or bladder dysfunction), such as overactive bladder, dysfunctional voiding, 
and underactive bladder had a clear definition in the literature. A definition of the 
broader concept “LUT dysfunction” was, however, lacking. We therefore defined LUT 
dysfunction ourselves. In Studies I and II, LUT dysfunction was defined as abnormal 
bladder capacity (bladder capacity exceeding 150% or less than 65% of that expected for 
age), abnormal urinary flow (tower, interrupted, fractionated, or plateau) and/or residual 
urine greater than 20 ml on repeated measuring. In Studies III–V, incontinence was 
added and the tower uroflow pattern withdrawn as signs of LUT dysfunction as advised 
by referees. Furthermore, urinary flow patterns representing disturbances in the 
emptying phase (staccato, interrupted, or plateau flow pattern) were summarized as 
discontinuous urinary flow patterns in these latter studies.      
 
4.3.3 Polyuria and oliguria 
Polyuria was defined as a urine output of 2000 ml/m² body surface area or more per 24 
hours [47] and oliguria as less than  300 ml/m
2
.    
  
4.3.4 UTI 
UTI was defined as significant bacteriuria, greater than 10
5 
cfu/ml, for which 
antibacterial treatment was started on the clinical suspicion of UTI. Recurrent UTI was 
defined as 2 or more UTIs.   
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4.4 METHODS  
An overview of the measures in Studies I–V is presented in Table 3. 
 
4.4.1 Renal function 
The glomerular filtration rate (GFR), reflecting renal function, was examined in all 
children according to the pre- and post-transplant programs. Different methods were 
used depending on such factors as tolerability for the child, ward staff resources, and 
changes in clinical practice. GFR can be assessed from the renal clearance of inulin or 
iohexol or estimated using the plasma level of cystatin C. 
     
4.4.1.1 Plasma clearance of inulin 
A substance, inulin (Inutest, 25% [sinistrin]; Fresenius Kabi, www.fresenius-kabi.no) is 
administered intravenously as a continuous infusion after a prime dose. A standard 
clearance technique, induced by oral intake of water in order to maintain adequate 
diuresis and enable the child to empty the bladder, consists of four urine collection 
periods with blood samples midway during each collection period. The mean value of 
the four clearance periods is calculated [126]. The method is viewed as the gold standard 
for kidney function assessments [127]. 
 
4.4.1.2 Plasma clearance of iohexol 
The method of plasma clearance of iohexol (Omnipaque 300 mg/ml; GE Healthcare, 
md.gehealthcare.com) is based on a sloping curve of plasma concentration or a single-
point measurement. A small dose of iohexol is administered intravenously and blood 
samples are collected from the contralateral arm after 180, 200, 220 and 240 minutes if 
GFR is > 50 ml/min/1.73 m²; otherwise, the time span to the first blood sample has to be 
increased [128]. This method has shown good agreement with renal clearance of inulin 
except in the lower range of GFRs [128]. 
 
4.4.1.3 Cystatin C estimated GFR 
Cystatin C is an endogenous, small molecular weight protein that is produced by all 
nucleated cells in the body at a constant rate and eliminated solely by the kidneys. One 
of the advantages of cystatin C, compared to s-creatinine, is that it can detect even mild 
forms of GFR impairment [129]. A single blood sample of a very small amount (0.5 ml) 
is sufficient for the analysis.   
 
4.4.2 Review of medical records 
The children’s medical records were subjected to a retrospective review in Studies II and 
III in order to obtain information about patient characteristics, ongoing medication, and 
earlier UTIs and GFR. The history of earlier UTI episodes was also ascertained by 
questioning the children and their caregivers. 
    
4.4.3 Evaluation of LUT function 
Evaluations and investigations of LUT function were performed according to the ICCS 
guidelines [46, 47] unless stated otherwise. 
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Table 3. Overview of measures used in Studies I to V.  
 
 Study 
 I II III IV V 
Measures      
GFR x  x  x 
Questionnaire/voiding habits, (ICIQ-FLUTS) x  x x (x) 
Bladder diary     x x x 
Uroflowmetry x x x x x 
Bladder ultrasound x x x x x 
Cystometry    x  
Medical records (retrospective review)  x x   
Kidscreen-27     x 
Disabkids-37 (DCGM-37)     x 
Subjective health and symptom inventory     x 
 
 
4.4.3.1 Bladder diary 
Different protocols for evaluating micturition habits have been used and called by 
different names in clinical contexts and research, e g., bladder diary, voiding diary, 
frequency-volume chart, questionnaire concerning micturition habits, etc. In Studies I 
and II, the aim of a questionnaire concerning micturition habits to be completed by the 
child or family at home was to record voiding-related symptoms and conditions. The 
questionnaire was then discussed at the clinical appointment with the urotherapist. In 
studies III, IV, and V, a 48-hour frequency-volume chart with daytime and nighttime 
recordings of volumes was added to the investigations of bladder function.          
 
4.4.3.2  ICQ-FLUTS inventory 
To ensure adequate data concerning LUT function, the Swedish version of the 
International Consultation on Incontinence Questionnaire Female Lower Urinary Tract 
Symptoms (ICIQ-FLUTS) inventory [130] was used in Study V as a complement to the 
comprehensive history mentioned above. The questionnaire also allowed grading of the 
severity of the symptoms on a ten-point Likert scale. The ICIQ-FLUTS inventory is a 
psychometrically validated instrument for assessing LUT in females of all ages and was 
chosen in this study due to the lack of validated questionnaires regarding LUT 
symptoms (LUTS) in children. 
 
4.4.3.3 Uroflowmetry 
All patients studied were examined using uroflowmetry for voiding patterns and, in 
Studies I–II, to measure maximum voided volumes. The uroflowmeter (Urodyn 1000, 
Medtronics Dantec, Skovlunde, Danmark) was installed underneath a toilet-like chair 
and placed in a natural toilet milieu where the child was allowed to sit relaxed and 
undisturbed. The child was properly informed about the procedure and asked to wait 
until the desire to void was strong. The child was encouraged to maintain a normal fluid 
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intake. The measurement was repeated at least once and the most normal flow curve was 
used for the evaluation.        
 
A tower-shaped curve, produced by a powerful voiding contraction, appears as a steep 
rise and falls in flow with a high Qmax and may represent a condition of suspected 
bladder overactivity. A staccato-shaped curve is seen as a continuous but fluctuating 
flow with sharp peaks and troughs and displays intermittent sphincter overactivity 
throughout the voiding. A fractionated flow curve is characterized by interrupted 
voiding with discrete peaks displayed on the curve corresponding to the abdominal 
straining to achieve bladder emptying and suggesting an underactive detrusor. The flow 
pattern is displayed as separated peaks on the curve and segments with no flow between 
these peaks. A plateau-shaped curve is a recording of a flattened, prolonged outflow 
suggesting organic bladder outlet obstruction [46, 47].              
 
4.4.3.4 Bladder ultrasound 
Bladder ultrasound for detecting post void residual urine was performed within five 
minutes after uroflowmetry using real-time equipment, Aloka SSD-500 (Tokyo, Japan) 
or Aloka Prosound across the examinations. The assessment was repeated at least once. 
The smallest amount of residual was recorded. Volumes of 20 ml or more on repeated 
occasions were considered clinically significant. All uroflowmetry and bladder 
ultrasound measurements were performed by the same investigator.   
 
4.4.3.5 Cystometry  
The invasive urodynamics (cystometry) in Study IV was performed using standard 
techniques [78], and all investigations were conducted by the same personnel. All 
enrolled children were carefully prepared following the local preparation program for 
children and parents before transurethral catheterization. As a complement to the oral 
and written information, the procedure was demonstrated in an interactive manner using 
illustrative pictures and play material (doll and catheter) for the child and the caregiver 
[76]. All children were offered the possibility to watch a film as distraction during the 
procedure. 
 
During the investigation the child was in a sitting or half-sitting position. The 
urodynamic equipment, Duet® Logic/MultiP (Medtronic AB, Sweden), was used for all 
studies. A 2-lumen 6 Fr catheter for cystometry was inserted and the bladder was 
completely emptied before starting the investigation. A rectal catheter was used to 
obtain an abdominal pressure. Both of these water-perfused catheters (3 ml/h) were 
connected to pressure transducers which recorded intravesical and abdominal pressures 
from which detrusor pressure was calculated (p ves – p abd). EMG activity was 
recorded simultaneously by perianally placed surface electrodes. Body-warm saline 
(0.9%) was infused at a rate of 5–10% of the expected bladder capacity (EBC) or of the 
maximum voided volume if that was known (from the bladder diary) to be significantly 
more than the EBC, expressed in ml/min. EBC was obtained using the formula 30 + (30 
x age in years) ml up to 500 ml [47]. The filling was terminated at a high baseline 
detrusor pressure (> 50 ml/cm H2O), at urge, complaints or uneasiness, at micturition, at 
an infused volume of > 150% of EBC with a detrusor pressure at the same time 
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exceeding 20 ml/cmH2O, or at continuous leakage. In order to get a reliable result, the 
filling was performed twice and the second cycle was used for analysis. The parameters 
of interest during the filling procedure were detrusor activity, compliance, bladder 
sensation, bladder capacity, maximal detrusor pressure, and leakage. These parameters 
were defined and suggested by the ICCS [47]. To our knowledge, there are no 
internationally accepted definitions of reduced bladder sensation, reduced bladder 
compliance, and large bladder capacity. In this thesis, reduced bladder sensation was 
defined as a weak or no sensation of bladder filling at greater than EBC for age, a 
reduced compliance as compliance lower than 5% of the EBC in ml (expressed as ml 
per cm H2O), and a large bladder capacity as a filling exceeding 150%  of the EBC 
without a desire to void.                       
   
4.4.4 Evaluation of HRQoL  
The QoL instruments, Kidscreen-27 and DCGM-37 self-reports, were used in Study V. 
The study group completed both of them on the same occasion during the clinical visits.  
  
4.4.4.1 Kidscreen-27 
The KIDSCREEN project developed a set of three HRQoL questionnaires including 
proxy versions for parents/caregivers, intended for 8 to 18-year-old healthy children and 
adolescents and those with chronic conditions. The project was carried out cross-
culturally with 13 participating European countries. The identified dimensions 
describing HRQoL in the Kidscreen-27 were Physical Well-being, Psychological Well-
being, Autonomy & Parent Relations, Social Support & Peers, and School Environment 
[95]. All items in the Kidscreen-27 refer to the latest week and the respondent gives a 
score on a 5-point Likert scale ranging from 1 (poor/not at all/never) to 5 
(excellent/extremely/always). The raw scores from different dimensions were entered 
into SPSS statistical tool according to the guidance given in the handbook [95]. The 
different steps in the process result in T-values with means of 50 and a standard 
deviation of 10, with higher values indicating a better HRQoL. The Kidscreen-27 has 
been shown to be a valid measure of HRQoL in children and adolescents when tested 
psychometrically and cross-culturally [131, 132].        
  
4.4.4.2 DCGM-37 
The DISABKIDS questionnaires were developed in collaboration with seven European 
countries for the assessment of HRQoL involving children and adolescents with 
different chronic diseases and their proxies. The DISABKIDS self-reported measures, 
targeted at 8–16-year-old children and adolescents, include a chronic generic part, the 
DCGM-37, and seven condition-specific modules (asthma, arthritis, epilepsy, cerebral 
palsy, diabetes, atopic dermatitis, and cystic fibrosis). The DISABKIDS measure is 
available in short and long versions, as well as proxy versions. The longer version, 
DCGM-37, was used in this thesis and consists of 37 items belonging to 6 dimensions of 
HRQoL: Independence, Emotion, Social inclusion, Social exclusion, Physical limitation, 
and Treatment. All items refer to the last four weeks in question and use a Likert scale 
ranging from 1 to 5 (never, seldom, quite often, very often, and always). Raw scores 
from the dimensions are calculated and transformed using standard scoring algorithms 
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for the instrument, resulting in scale scores in a possible range of 0 to 100 [125]. The 
transformed summary data were used in our analyses with a higher score indicating a 
better HRQoL. DCGM-37 has been shown to have satisfactory reliability and validity in 
psychometric tests [99]. 
 
4.4.5 Comparison groups (Study V) 
A comparison group of 500 individuals, aged 11–23, was randomly selected from the 
Swedish population registry (SPAR). Of these subjects, 257 (54%) participated and 
completed the Kidscreen-27 by telephone interviews, as has been reported elsewhere 
[124]. From this group, 203 age-matched participants were included in the present study 
for comparison with the general population. For comparisons with children with other 
chronic diseases, DCGM-37 data from the field studies provided by the DISABKIDS 
group [99] were used. 
 
4.4.6 Subjective health and symptom inventory 
In study V a self-assessment checklist covering subjective health and symptoms was 
used in order to further describe the patient group and get a better understanding of 
problems which may affect the everyday life of children living with CKD or a renal 
transplant. The checklist, designed and previously used for children with allogeneic stem 
cell transplants [133], was modified for use in children with CKD. The children were 
asked about participation in physical exercise activities and about selected subjective 
symptoms (fatigue, nausea, itching, headache, pain, heart/pulmonary problems, sleeping 
disturbances). They were also asked if they considered themselves to be overweight or 
short. Symptoms appearing most frequently were reported.   
 
 
4.5 STATISTICAL ANALYSES 
4.5.1 Descriptive statistics 
Numbers and percentages were used to describe the distribution of patients and 
characteristics. The mean and the standard deviation were used when the data were 
normally distributed. The median and the range (min – max) were presented for non-
normally distributed data. 
 
4.5.2 Statistical methods 
The statistical analyses were performed using Statistica (StatSoft Inc.) in Studies I–III 
and IBM SPSS Statistics (version 20 for Windows, IBM Corp) in Study V. Statistical 
significance was set at p < 0.05 throughout the studies. 
 
Non-parametric statistics were used in Studies I and II. Chi-square testing was 
performed to test for differences between two proportions in categorical variables, and 
Kruskall-Wallis to test more than two groups. The Mann-Whitney-U test was used to 
test continuous variables in Study II. Fisher’s exact test was used for categorical 
variables and Student’s t test for continuous variables in Study III. Linear regression 
analyses were performed for correlation studies. Differences within and between groups 
were analyzed using independent-samples t-tests in Study V.  
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6 RESULTS 
All the studies (I–V) have a focus on bladder function in children with CKD or a renal 
transplant. Since the kidney disease was usually progressing from mild to severe forms 
of CKD to ESRD requiring dialysis or transplantation, the results from the studies in this 
thesis are presented in that order. Thus, the results from Studies III and IV are presented 
first, followed by Studies I and II and, finally, Study V.     
    
 
6.1 LUT DYSFUNCTION IN CHILDREN BEFORE AND AFTER RENAL 
TRANSPLANTATION AND ASSOCIATION WITH UTI 
 
6.1.1 LUT dysfunction and CKD (Study III)  
The aim of Study III was to evaluate the prevalence and type of LUT signs and 
symptoms in children with CKD stages 3–5 and to compare signs and symptoms in 
these children with and without underlying urological disorders, and, furthermore, to 
report data concerning UTI. Eight (20%) of the included 40 children suffered from 
incontinence, 19 children (47.5%) had a large bladder capacity, 8 children (20%) had a 
discontinuous urinary flow, 12 children (30%) had a tower flow pattern, and 6 children 
(15%) had post void residual urine of 20 ml or more (Figure 3). Twenty-nine of the 
children (72.5%) showed one or more signs of LUT dysfunction (incontinence, 
large/small bladder capacity, and discontinuous urinary flow and/or post void residual 
urine). A large bladder capacity was the most common finding, followed by 
incontinence and discontinuous urinary flow.   
 
Signs of LUT dysfunction were present in all 13 children (100%) with urological 
diseases and in 16 of 27 children (59%) with non-urological diseases. Mean age, GFR, 
and urine output, as well as the proportion of children with incontinence and small 
bladder capacity, were similar in these two groups. Large bladder capacity, a 
discontinuous urinary flow, and post-void residual urine were slightly more common in 
children with urological diseases, but the differences did not reach statistical 
significance. 
 
Forty percent of all children had experienced one or more febrile UTIs, but infections 
were significantly more common in children with urological diseases, compared to those 
with non-urological disorders (77% vs. 22%, p = 0.0017), and in children with signs of 
LUT dysfunction compared to those with normal LUT function (55% vs. 0%, p = 
0.0012). 
 
6.1.2 Evaluation of LUT dysfunction with cystometry (Study IV) 
The aim of Study IV was to further define LUT function in children with CKD in stages 
3–5 and to compare the evaluation of bladder function using invasive urodynamics 
(cystometry) with non-invasive methods. From the previous cohort of 40 children 
(Study III), 29 with signs of LUT dysfunction (incontinence, large bladder capacity, 
discontinuous urinary flow, post-void residual urine), as evaluated with non-invasive 
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methods (history, bladder diary, uroflowmetry, bladder ultrasound) were recommended 
cystometry. Seventeen children accepted and underwent the investigation. A large 
cystometric bladder capacity (CBC) was the most common finding (12/17 children, 
70.6%). A reduced bladder sensation was often combined with this finding (9 of 12, i.e., 
75% of the children with a large CBC; 9 of 17, i.e., 52.9% of all children). No other 
cystometric abnormalities were found in the 12 children with a large CBC. Other 
abnormalities were found in two children (11.8%): one of them had a reduced 
compliance and reduced bladder sensation, and the other had reduced compliance and 
detrusor overactivity. Normal results were found in 3 of the 17 children (17.6%). A large 
bladder capacity and reduced bladder sensation was common in children with both 
urological and non-urological disorders. Detrusor overactivity and reduced compliance 
were observed only in children with urological disorders. 
  
Results from the non-invasive screening revealed a large maximum voided volume in 10 
of 17 children (58.8%) as the only abnormality. The results were confirmed by 
cystometry in 8 of 10 cases. In the remaining two cases, cystometry results were found 
to be normal. These two children had a maximum voided volume amounting to 160–
165% of EBC for age (i.e., just above the upper limit of normal), but no other 
abnormalities in the non-invasive evaluation. The non-invasive screening showed 
abnormalities other than a large maximum voided volume in seven children (41.5%). In 
these children, the cystometric evaluation revealed normal results in one child, a large 
bladder capacity in four children, and other abnormalities in two. In children with a large 
maximum voiding volume as a single finding at screening, cystometry confirmed this or 
revealed normal findings.   
         
6.1.3 LUT dysfunction after renal transplantation (Study I) 
The aim of Study I was to report the incidence and type of LUT dysfunction in pediatric 
renal transplant recipients, to study the incidence of LUT dysfunction in different 
diagnostic groups, and, furthermore, to study the possible influence of LUT dysfunction 
on renal function. Sixty-eight children participated. One or more signs of LUT 
dysfunction were found in 49 children (72%). Post-void residual urine (in 22/68, 32%), 
abnormal bladder capacity (in 17/65, 26%), and abnormal urinary flow (in 34/68, 50%) 
including a tower flow pattern (in 22/68, 32%), were the most observed signs of LUT 
dysfunction (Figure 3). These findings were equally prevalent in children with 
congenital disorders with and without urological malformations and acquired disorders. 
Urinary incontinence was found in 8 (12%) of the 68 children. The groups with and 
without LUT dysfunction did not differ statistically regarding GFR. 
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Figure 3. The percentage of different signs and symptoms of LUT dysfunction in 
children before and after renal transplantation. 
 
6.1.4 UTI and LUT dysfunction after renal transplantation (Study II)  
The aim in Study II was to evaluate the association between LUT dysfunction and UTIs 
in children with a kidney transplant and to study the impact of recurrent UTIs on graft 
function.  
Almost half of the children in Study I (33/68, 48%) had experienced one or more UTIs 
after renal transplantation. UTIs were recurrent in 25 children (25/68, 37%). LUT 
dysfunction (abnormal urinary flow, abnormal bladder capacity for age, and/or post-void 
residual urine) was equally prevalent in children with and without recurrent UTI (68% 
vs. 74%, NS); nor did post-void residual urine influence the recurrence rate of UTIs. 
Urinary tract malformations was significantly more common in children with recurrent 
UTIs than in those without (44% vs. 9%, p = 0.009) and was the only identified risk 
factor for UTIs among the children investigated. 
 
GFR was significantly lower (mean GFR 45 vs 57 ml/min/1.73m², p = 0.02) at four 
years after transplantation in children with recurrent UTIs compared to those without, 
indicating a faster deterioration of renal function in those children. 
 
 
6.2 SELF-REPORTED HRQOL   
 
6.2.1 LUT dysfunction and associations to HRQoL (Study V) 
The aim of Study V was to investigate the association between LUT dysfunction and 
HRQoL in children with CKD or a renal transplant. The association with other potential 
risk factors, such as CKD status, sex, and age, on HRQoL was also studied. In addition, 
the results from the entire study population were compared with those from children 
with other chronic conditions and with healthy children. 
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At least one sign of LUT dysfunction (incontinence, large bladder capacity, 
discontinuous urinary flow, and/or post-void residual urine) was found in 32 (58%) of 
the children. These children experienced a HRQoL similar to that of those without LUT 
dysfunction, with the exception of children with incontinence, who reported physical 
limitations, lower in in the treatment dimension, and lower general score (Table 4). Girls 
and older children reported a lower HRQoL compared with boys and younger children. 
Children with a renal transplant rated a lower physical well-being and independence 
than did those with moderate to severe CKD. The entire study population reported an 
impaired HRQoL regarding physical and psychological well-being compared with the 
general population but a similar one to those with other chronic conditions.  
 
Table 4. Comparisons of self-reported HRQoL between groups with and without LUT 
dysfunction, urinary incontinence, and urological disorders. Mean and p values  
  
 
LUT dysfunction 
 
Incontinence 
 
Urological disorders 
  No Yes P 
a
 No Yes P 
a
 No Yes P 
a
 
N= 23 32 
 
44 15  39 20 
 
KIDSCREEN-27 
   
   
   
Physical Well-
being 
44.6 46.5 0.414 45.5 44.7 0.757 44.6 46.8 0.360 
Psychological 
Well-being 
49.4 50.3 0.750 50.1 47.9 0.484 50.3 47.9 0.407 
Autonomy & 
Parent relation 
53.9 51.0 0.227 53.1 48.5 0.079 53.0 49.7 0.169 
Social Support & 
Peers 
54.9 53.3 0.504 52.7 54.4 0.595 52.6 54.3 0.572 
School 54.3 53.4 0.727 53.9 53.1 0.781 54.2 52.6 0.531 
DISABKIDS-37 
   
   
   
Independence 78.8 80.7 0.673 81.1 75.8 0.279 80.3 78.5 0.690 
Physical limitation 73.4 76.3 0.544 77.7 66.9 0.035 78.6 67.3 0.017 
Emotion 74.8 74.3 0.934 77.3 65.0 0.057 76.3 69.9 0.302 
Social exclusion 84.8 82.2 0.559 84.7 76.4 0.100 84.8 77.9 0.139 
Social inclusion 76.2 75.3 0.858 75.0 74.2 0.873 75.6 73.2 0.619 
Treatment 80.2 69.0 0.078 78.9 57.5 0.002 71.9 76.2 0.481 
Total DCGM-37 78.0 76.3 0.685 79.1 69.2 0.020 77.9 73.9 0.322 
LUT, lower urinary tract  
LUT dysfunction = large MVV, post void residual urine, discontinuous urinary flow, and/or incontinence  
a
 Group mean differences were assessed with the independent-samples t test.  
 
 
6.3 SUBJECTIVE HEALTH SYMTOMS 
Associated subjective symptoms were reported by 50 (85%) of the children and were 
rated as mild by 23 (39%) or moderate to severe by 27 (46%). Twenty of the children 
with CKD (87%) reported mild (48%) or moderate to severe (39%) symptoms. Thirty of 
the children with a renal transplant (83%) reported mild (33%) or moderate to severe 
(50%) symptoms. The most reported subjective complaints were headache, fatigue, 
sleep disorders, short stature, and stomach disorders. 
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7 DISCUSSION AND FUTURE PERSPECTIVES 
The results from Studies I–V show that signs and symptoms consistent with LUT 
dysfunction are common in children with CKD both before and after transplantation. 
This finding is supported by the findings of Van der Weide et al. [59], but, otherwise, it 
has not been described earlier. 
 
LUT dysfunction was common in children with CKD, both before and after renal 
transplantation, and the cause of bladder dysfunction therefore does not seem to be the 
transplantation per se. More likely, LUT dysfunction is caused by factors already 
present before the transplantation, e.g., LUT abnormalities, polyuria, or oliguria. 
Moreover, children with CKD may suffer from disorders similar to those of the general 
population, for instance, functional bladder disorders and constipation. Unfortunately, 
the latter disorder was not included among the evaluated variables in this thesis, but it 
will be addressed in future studies. 
 
Definition of LUT dysfunction 
A main issue throughout this work has been the definition of LUT dysfunction. A clear 
definition of LUT dysfunction was lacking when we planned this project and is still 
lacking today. 
 
In Studies I and II we defined LUT dysfunction (at that time “bladder dysfunction”) in 
terms of urinary flow, a maximum voided volume (at that time “bladder capacity”), 
and/or a bladder emptying function that was not normal according to the ICCS 
guidelines [46]. This definition can, however, be questioned. Within the concept of LUT 
dysfunction, there are several conditions, such as, for instance, enuresis, overactive 
bladder, underactive bladder (former lazy bladder), and dysfunctional voiding. It is not 
clear, however, if these conditions exclusively or all signs and symptoms thereof that are 
not normal according to the ICCS guidelines qualify as LUT dysfunction. Furthermore, 
signs that under “normal conditions” are abnormal may not be so under other conditions. 
For instance, a voiding frequency of 3–7 voids per day presupposes a normal urine 
production. If a child suffers from polyuria, the daily voiding frequency or voided 
volumes will necessarily have to increase. Most children with overactive bladder empty 
the bladder with a tower-shaped curve, but there is no evidence that a tower-shaped 
curve always indicate an overactive bladder or other pathology. Furthermore, even 
though regarded as abnormal, this curve shape does not generally indicate a need for 
further investigation, as opposed to curves indicating a functional, anatomical, or 
neurological obstruction [51]. This topic has been debated comprehensively by scientists 
for years, but there is still room for individual interpretations [134]. 
 
The definition used in Studies I and II was later questioned by referees of Study III. 
They suggested that the tower urinary flow should be excluded and urinary incontinence 
included in the definition and since we agreed, we modified the definition accordingly. 
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LUT function before and after renal transplantation 
Patient characteristics and data on LUT function from Studies I–IV according to the 
latter definition (i.e., the definition in Papers III, IV, and V) are updated and presented in 
Table 5. By this concordant definition, LUT dysfunction was more frequent in children 
with CKD before than after renal transplantation (72.5% vs. 55.9%, NS). The proportion 
of children with incontinence, a small maximum voided volume/bladder capacity, a 
tower urinary flow, and a discontinuous urinary flow was, however, similar before and 
after transplantation. Only a large maximum voided volume/ bladder capacity was more 
usual before transplantation and residual urine was more usual after transplantation 
(Table 5). The latter difference did not reach statistical significance, however. 
 
A main finding within this project is the high proportion of large capacity bladders in 
children with CKD stages 3–5. Nearly half of the children had a maximum voided 
volume exceeding EBC for age at the non-invasive screening and in nearly 75% of the 
children investigated with cystometry, the large bladder capacity was combined with 
reduced bladder sensation. The results from Study III show that the maximum voided 
volume/bladder capacity increases with increasing urine production. It therefore seems 
probable that these large-capacity bladders are caused in most cases by a large urine 
output; however, other underlying mechanisms cannot be ruled out.   
 
A large cystometric bladder capacity or a large maximum voided volume is often 
associated with detrusor underactivity and incomplete bladder emptying or infrequent 
voiding [135] and, in such cases, a potential risk factor for UTIs, hydronephrosis, and 
renal damage. If, however, there is no hydronephrosis and normal intravesical pressure 
and bladder emptying is complete, the importance of a large bladder capacity or a large 
maximum voided volume is unclear. But when the urine output decreases, as will 
happen after renal transplantation, there are three possible scenarios. If the child retains 
habits from before renal transplantation and continues to drink excessively after 
transplantation, this behavior may maintain a large urine production and counteract 
normalization of the bladder capacity. If the child normalizes fluid intake and bladder 
sensation also normalizes, the patient will void at normal intervals and with normal 
voided volumes. If, however, bladder sensation does not normalize, the patient is at risk 
of developing infrequent voiding habits and, in the worst case scenario, UTIs [63]. In 
Study I, eight of 68 children (13.8%) had large capacity bladders after transplantation 
even though the mean urine production was lower in children after as compared to 
before renal transplantation (2210 ml vs.1366 ml per 24 hours, p < 0.01) and mean 
maximum voided volume decreased from 147% of EBC for age before transplantation 
to 104% after transplantation. The reason why some children have large capacity 
bladders even after transplantation is unclear, but it may be explained by the reasons 
discussed above. However, since we still have no longitudinal data extending from 
before to after transplantation, we do not know what happens at transplantation at the 
individual level and this obviously has to be explored in future studies.  
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Table 5. Patient characteristics and data on LUT function according to the definitions in 
Studies III–V. 
 
 Before Tx After Tx P value
‡
 
    
Number 40 68  
Age, years, mean ± SD 11.6  ± 4.1 14.4 ± 4.2  
Male sex (%) 27/40 (67.5%) 37/68 (54.4%) 0.2253 
Uro (%) 13/40 (32.5%) 15/68 (22.1%) 0.2607 
GFR, ml/min/1.73 m2, mean ± SD 25.4  ± 12.7 56.1 ± 20.6  
    
Urine production, ml, mean ± SD 2210 ± 1237 1366 ± 618 0.000021# 
Polyuria (%) 14/40 (35%) NA  
MVV, % of EBC for age, mean 147% 104% 0.0298# 
LUT function    
  Incontinence (%) 8/40 (20%) 8/68 (11.7%) 0.2713 
  Small MVV (%) 5/40 (12.5%) 8/65 (12.3%) 0.7736 
  Large MVV (%) 19/40 (47.5%) 9/65 (13.8%) 0.0002# 
  Tower urinary flow (%) 12/40 (30%) 22/68 (32.4%) 0.8335 
  Discontinous urinay flow (%) 8/40 (20%) 12/68 (17.6%) 0.8008 
  Residual urine (%) 6/40 (15%) 22/68 (32.4%) 0.0680 
LUT dysfunction (%)* 29/40 (72.5%) 38/68 (55.9%) 0.1027 
    
History of UTI (%) 16/40 (40%) 33/68 (48.5%)† 0.4284 
* Defined as presence of any of the following: urinary incontinence, abnormal bladder capacity, 
discontinuous urinary flow and/or residual urine more than 20 ml (alone or in combination). 
† Counted from one month after renal transplantation 
‡ Fisher’s exact test, two-tailed, for categorical variables and T-test for continuous variables. 
# Significant values 
 
As mentioned above, residual urine was more common after renal transplantation, 
compared with before. One possible explanation for this is that a bladder 
(over)distended by polyuria prior to transplantation does not regain normal emptying 
function after transplantation or that it takes time. This does not, however, seem likely 
since most children examined before transplantation could empty their bladders 
completely despite a large bladder capacity before transplantation and only one out of 
eight children with a large bladder capacity after transplantation had residual urine.  
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Other potential explanations may be neurological complications and/or adverse effects 
of medication. 
 
LUT dysfunction in different disease groups 
LUT dysfunction was common in children with both urological and non-urological 
diseases. Before transplantation LUT dysfunction was more prevalent in children with 
urological disease compared to those with non-urological diseases (100% vs. 59%), but 
no difference in various disease groups was found after transplantation. 
 
In Studies I and II, pediatric transplant recipients were categorized into three different 
groups according to the underlying diseases: congenital disorders with urinary tract 
malformations, congenital disorders without urinary tract malformations, and acquired 
disorders. Since the number of patients was small and the frequency of LUT dysfunction 
did not differ between the three groups, we decided to reduce the number of groups and 
categorize the children to either urological or non-urological disorders in the remaining 
studies (III to V). Another reason for this was that LUT function was previously 
evaluated mainly in children with urological diseases and little was known about other 
underlying disorders. It therefore seemed natural to compare urological diseases with 
non-urological diseases. Since we had no children with acquired urological disorders, all 
children categorized as having congenital disorders with urinary tract anomalies in 
Studies I and II were categorized as having urological disorders in Studies III–V. All 
other children were categorized as having non-urological disorders. 
  
LUT dysfunction and UTI 
The incentive for this thesis was our concern for the children with recurrent UTIs, but 
the thesis finally came to focus more on LUT function in children with CKD than on 
UTI. Nevertheless, the results concerning UTIs are worth discussing. In the CKD group 
(children with CKD but without a renal transplant) recurrent UTIs were more usual in 
children with LUT dysfunction than in those with normal function. The frequency of 
earlier UTIs was highest in children with emptying difficulties (discontinuous urinary 
flow and/or residual urine) (78%) and those with urological disorders (77%) and lowest 
in children without any sign of LUT dysfunction (0%). The frequency of UTIs in 
children with bladder dysfunction was 55%. 
 
In children with a renal transplant, no association between LUT dysfunction and UTIs 
was found. This finding was surprising since the association between LUT dysfunction 
and recurrent UTIs is well established in the general pediatric population [136]. A 
possible explanation for the lack of association is that the UTI frequency was 
overestimated. Information regarding UTI was obtained from the medical records and 
the diagnosis was based on the combination of a suspicion of UTI, a positive urine 
culture, and subsequent antibiotic treatment. It is, however, possible that the high degree 
of surveillance might have led to too generous diagnosing of UTI. This suspicion may 
be supported by the fact that we report a slightly higher incidence of UTI than in other 
studies [5]. Another, perhaps even more probable, explanation is that we overestimated 
the frequency of bladder dysfunction by including a tower flow pattern in the definition. 
Hopefully, future prospective studies will clarify this issue.  
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Even though it is possible that they were not caused by LUT dysfunction, recurrent 
UTIs in renal transplant recipients were associated with a more rapid decline in graft 
function. This conflicts with the results from some groups [3, 137], but is supported by 
others [138-140]. One possible explanation for the conflicting results is that we had a 
longer follow-up compared to others. However, the results underline the importance of 
continuing efforts to clarify the underlying mechanisms that promote UTIs after renal 
transplantation and what consequences UTIs may have in this patient population.  
 
LUT dysfunction and HRQoL 
Study V concerning HRQoL was added to this project in order to find possibly links 
between everyday problems and LUT dysfunction in children with CKD or a renal 
transplant. In clinical practice, a subgroup of these children is given advice about, for 
instance, timed voiding and double voiding in order to normalize bladder capacity and 
counteract post void residual urine with the intention to prevent UTIs. However, in 
actual clinical practice, the children with CKD or a renal transplant seldom adopt this 
advice, which makes one wonder whether these signs and symptoms of LUT 
dysfunction bother the children or not. A knowledge of how these children rate their 
HRQoL and whether HRQoL is influenced or not by signs of LUT dysfunction may 
provide information and guidance concerning what aspects and interventions might be 
of value in the care of children with CKD or of renal transplant recipients with LUT 
dysfunction.  
  
Study V revealed that LUT dysfunction, in terms of a discontinuous urinary flow, a 
large bladder capacity, post-void residual urine, and/or incontinence, did not generally 
affect well-being in the everyday life of children with CKD or a renal transplant, 
compared to those without these signs. However, some important findings were that the 
subgroup of children with incontinence reported lower HRQoL in the areas Physical 
limitation and Treatment and a lower total score and that the children with CKD with 
urological disorders reported a lower score in the area Physical limitation. To the best of 
my knowledge, the impact of LUT dysfunction on HRQoL has been very sparsely 
studied in this population, but with regard to incontinence and children with CKD due to 
urological disorders, similar findings were reported by Dodson et al. [108, 141]. Other 
aspects of LUT dysfunction such as a discontinuous urinary flow, a large bladder 
capacity, and post-void residual urine, were more prevalent, but did not affect HRQoL. 
It is possible that, in contrast to incontinence, which is known to affect HRQoL even in 
healthy children [53, 54, 142], abnormal urinary flow, large bladder capacity and post-
void residual urine may not have a priority in the everyday life of these children. An 
alternative explanation may be that these children simply do not take notice of these 
conditions. This new information might help healthcare professionals to find feasible 
strategies for advising these children with respect to large voiding volumes and post 
void residual urine and not to overlook the incontinence. 
  
HRQOL in children with CKD or a renal transplant 
To gain knowledge about potential associations between HRQoL and everyday life in 
children with CKD or a renal transplant, we also evaluated differences in well-being 
between boys and girls, younger and older children, and between children with moderate 
to severe CKD and those with a renal transplant. Well-being in the entire group was also 
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compared to that of children in the general population and children with chronic 
conditions other than CKD. 
 
Impairments in HRQoL in girls and older children in this study might not be a surprising 
finding; a number of authors have previously reported similar findings regarding 
children with CKD [143] and other chronic conditions [142, 144], as well as regarding 
healthy children [145-147]. The discrepancy between younger and older children may 
be explained by developmental processes, including a physical and social transition 
from childhood to adulthood, and an adaptation to a changing body and a new gender 
identity [148]. Pubertal development is known to start earlier and is more sudden in 
girls, so as to require a more rapid physical and psychological adjustment [148]. 
 
CKD or transplantation-related complications, such as anemia, short stature, and weight 
gain, have been reported to influence HRQoL negatively [102, 122, 143] and may 
influence HRQoL more in girls and older children since we know that older children and 
girls are more prone to worry about their bodies and appearance [145, 147]. However, it 
should be mentioned that, although the two age groups in our study were similar in the 
number of children, girls dominated the older age group, which may have affected the 
results. Despite a potential bias in age categories, the results still underline the 
importance of identifying factors that contribute to impaired HRQoL in girls and older 
children.                     
 
Renal transplantation is a well-established treatment for children with ESRD and yields 
excellent treatment outcomes [26, 27]. The unexpected finding that renal transplant 
recipients, despite a higher GFR (mean, 55 vs. 29 ml/min/1.73 m²), reported lower well-
being compared to children with moderate to severe CKD (stages 3–5) deserves to be 
mentioned, as one might expect, if not entire recovery, then at least improved health. 
However, this finding may have been influenced by the fact that none of the children 
with CKD stage 3 to 5 were on dialysis. Clinical improvement in children after renal 
transplantation is expected to have a favorable effect on HRQoL compared to those on 
dialysis, as has been confirmed by a number of studies [35, 112, 115, 116, 149]. There 
are few studies comparable to ours, but, in an article by McKenna et al., similar 
observations were reported [106]. In our study, children with a renal transplant rated 
lower in the dimensions Physical well-being and Independence than did those with 
moderate to severe CKD, which may reflect many challenges in everyday life that these 
children still have. Concerns about physical problems such as short stature, overweight, 
and exercise capacity, as well as the necessity of lifelong medication and a fear of graft 
loss are some of the possible factors with a negative influence on HRQoL [34, 119-123]. 
The experience of a life-threatening disease may contribute to overprotective attitudes 
from parents and healthcare staff, which, in turn, limits the development of an 
autonomous life of the child and may lead to a lower perceived HRQoL in this area 
[120, 150, 151]. However, the discrepancy in the HRQoL areas Physical well-being and 
Independence, which is disadvantageous for renal transplant recipients, calls for a more 
extensive evaluation. What we did not investigate, but should analyze in future studies, 
is the influence of other possible factors such as socioeconomic issues, rejection 
episodes, and associated complications.  
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Subjective symptoms such as headache, fatigue, sleep disorders, poor growth, and 
stomach complaints were equally common both before and after transplantation, but 
they were reported to be more troublesome by children with a renal transplant. The 
measure was aimed at describing the study population; however, a possible association 
with impaired HRQoL needs to be elucidated in further studies. 
 
Ratings from children with CKD stages 3 to 5 and renal transplant recipients revealed a 
similar picture in all HRQoL areas in comparison with children suffering from asthma, 
arthritis, cerebral palsy, cystic fibrosis, dermatitis, epilepsy, or diabetes mellitus. 
However, the entire study population reported an impaired HRQoL regarding Physical 
and Psychological well-being in comparison with children from the general Swedish 
population. This finding was, however, not surprising, because other authors have 
reported similar findings [119, 120, 123]. The results suggest that a renal transplantation, 
even though constituting a lifesaving treatment, still results in a chronic condition that 
may have an adverse influence on everyday life in many ways. It is important, however, 
to transform this information into a clinical context and to find ways to meet every 
child’s unique prerequisites and needs. To gain a more in-depth knowledge of needs in 
the everyday life of pediatric renal patients with and without LUT dysfunction, a study 
using qualitative methods might be a preferable approach. 
  
  
7.1 METHODOLOGICAL CONSIDERATIONS 
Strengths and shortcomings 
One strength of this study is the unique approach. Associations with LUT dysfunction 
before and after renal transplantation have not been widely studied so far in children 
with CKD of other causes than urological ones. Thus, the present study, although 
comprising a limited number of participants, serves as a valuable contribution to 
increasing knowledge about LUT dysfunction in children before and after renal 
transplantation, regardless of whether the underlying disease is of urological or non-
urological origin. 
 
An additional strength of this study is that a large proportion of Swedish children with 
CKD was included. However, since the prevalence of CKD in children is low, the 
number of patients is, nevertheless, relatively small. This makes it difficult to draw firm 
conclusions. My intention is therefore to continue studying this patient population 
prospectively and longitudinally through different CKD stages and beyond renal 
transplantation. Hopefully, this will make it possible to determine the association and the 
nature of the association between the cause of the underlying disease, bladder function, 
UTIs, and deterioration of renal function more clearly. 
 
An additional limitation in this thesis is the absence of comparison groups in studies I to 
III. Limited financial support forced us to rely on historical controls. Hopefully the 
results from this thesis can generate better financing for future studies. 
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8 CLINICAL IMPLICATIONS 
The findings in this thesis imply that identification of LUT dysfunction in children with 
CKD is important. A clinical evaluation using non-invasive methods (detailed voiding 
history, frequency-volume chart, uroflowmetry, and bladder ultrasound for measuring 
post void residual urine) might already be justified in stage 3, regardless of the 
urological and non-urological disease background, but of course earlier when urological 
anomalies are known. This early screening and recognition of LUT dysfunction allows 
correction and prevention of the worsening of dysfunction in the long term, especially 
with respect to renal transplantation. Attention to the children with polyuria, with the 
risk of developing a large capacity bladder and reduced bladder sensation, is warranted 
in order to prevent the development of bladder emptying problems and subsequent 
UTIs. However, since the number of patients in this study is limited, the results must be 
confirmed in larger studies before definitive recommendations can be given. 
 
Our knowledge about the physical, psychological, and social well-being of children who 
are undergoing medical treatments due to various chronic conditions has become an 
important key area in monitoring treatment outcomes. This information can distinguish 
severe clinical problems from other outcome perspectives than medical ones, which are 
important to be detected and addressed at medical follow-up visits. HRQoL data in this 
thesis provided information about the association between urinary incontinence and a 
negative influence on well-being. This is an additional finding to the already existing 
ones supporting the need for awareness of the problems associated with urinary 
incontinence in children with CKD. 
 
This thesis recognized lower well-being in some of the areas in children with a renal 
transplant, as well as in girls and older children. Additionally, physical and 
psychological impairments were evident in the entire patient group compared to children 
in the general population. To prove causality in these issues will require more evaluation 
in further studies. However, the present results point out significant problems implying 
that it is important to acknowledge psychosocial issues at clinical follow-up visits and 
that the need for supportive interventions should be considered. 
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9 SUMMARY AND CONCLUSIONS 
From the studies included in this thesis, we conclude that:  
 
 Signs and symptoms consistent with LUT dysfunction are frequent in children 
with CKD stages 3 to 5 and in pediatric renal transplant recipients. 
 
 A large bladder capacity is the most frequent sign of LUT dysfunction in 
children with CKD stages 3–5. A large bladder capacity is often combined with 
reduced bladder sensation. 
 
 Residual urine is the most frequent sign of LUT dysfunction in pediatric renal 
transplant recipients. 
 
 LUT dysfunction is more frequent in children with urological disorders, but it 
also occurs frequently in children with non-urological disorders children with 
CKD stages 3–5. In pediatric renal transplant recipients, LUT dysfunction was 
equally frequent in children with urological and non-urological disorders. 
 
 A history of UTIs was more frequent in children with LUT dysfunction than in 
those with normal LUT function in CKD stages 3–5, but this association was not 
found in pediatric transplant recipients. 
 
 Among children with CKD stages 3–5 and no signs of LUT dysfunction, no 
child had experienced earlier UTIs. 
 
 Among children with CKD stages 3–5 and discontinuous urinary flow and/or 
residual urine, 78% had experienced earlier UTIs. 
 
 Renal function in children with recurrent UTIs after renal transplantation 
deteriorated faster than in children with one or no UTIs. 
 
 Children with CKD stages 3–5 and pediatric renal transplant recipients with and 
without LUT dysfunction reported similar HRQoL, with the exception of 
children with incontinence. Children with incontinence reported physical 
limitations and treatment-related concerns. 
 
 
Since signs and symptoms consistent with LUT dysfunction are common in 
children with CKD, regardless of the underlying cause of the disease, I recommend 
all children with CKD to be screened for LUT dysfunction. 
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10 SVENSK SAMMANFATTNING 
Kronisk njursjukdom (CKD) hos barn är ett livslångt tillstånd. Sjukdomen är ovanlig, 
uppskattningsvis har ca 120 barn i Sverige en allvarlig eller grav 
njurfunktionnedsättning. CKD är en progredierande sjukdom som delas in i olika 
svårighetsgrader (CKD stadier 1–5). I dess mildare former ger sjukdomen sällan några 
symtom och upptäcks inte alltid, men med tilltagande njurfunktionsnedsättning 
framträder allt fler komplikationer. I slutstadiet är dialys eller njurtransplantation de 
återstående och livsuppehållande behandlingsalternativen. Vanliga symptom och 
komplikationer som illamående, trötthet, anemi, högt blodtryck, proteinuri, 
kortvuxenhet, neurokognitiva förseningar eller biverkningar av medicinering är vanliga 
hos barn med CKD stadium 3–5 och även till viss del hos de som genomgått en 
njurtransplantation. Behandlingen syftar till att förebygga och behandla komplikationer, 
samt att förhindra försämring av njurfunktionen. Urinvägsinfektioner (UVI) är en vanlig 
komplikation som kan skada njurarna. Blåsdysfunktion (”LUT dysfunction”) är en känd 
riskfaktor för UVI hos friska barn, men det saknas kunskap om blåsdysfunktion hos barn 
med CKD eller som har genomgått en njurtransplantation. CKD eller njurtransplantation 
ställer krav på många aspekter i vardagslivet hos barn och därför är också barnets 
välbefinnande ett viktigt utfallsmått att beakta i vården av dessa barn. Det övergripande 
syftet med denna avhandling har varit att utvärdera de nedre urinvägarnas/urinblåsans 
funktion före och efter njurtransplantation, samt att studera vilken roll blåsdysfunktion 
har i relation till urinvägsinfektioner. Ett ytterligare syfte har varit att ta fram kunskap 
om eventuell association mellan blåsdysfunktion och HRQoL.    
 
Alla fem delarbeten var tvärsnittstudier och inkluderade 40 barn med CKD stadium 3–5 
(studier III och IV), 68 barn som genomgått njurtransplantation (studier I och II), och 59 
barn med CKD stadium 3-5 (n=23) eller njurtransplantat (n=36) i studie V. Barnen 
genomgick en kartläggning av blåsfunktionen med strukturerad miktionsanamnes, 
miktionsdagbok, upprepade urinflödesmätningar för bestämning av 
blåstömningsmönster, ultraljud av urinblåsan för bestämning av residualurin samt i 
studie IV också cystometri. Njurfunktionen undersöktes med inulin- eller 
iohexolclearance, eller estimerades utifrån plasmavärdet av cystatin C. Uppgifter om 
tidigare UVI hämtades från patientjournaler. I studie V användes två frågeformulär, 
Kidscreen-27 och DCGM-37 för självrapportering av HRQoL och ett modifierat hälso-
och symtomformulär för rapportering av associerade subjektiva symptom. 
Blåsdysfunktion definierades i studierna I och II som onormalt urinflöde, residualurin 
>20 ml, och/eller onormalt liten eller stor blåskapacitet och i studierna III till V som 
inkontinens, liten/stor maximal blåsvolym, oregelbundet urinflödesmönster och/eller 
residualurin. 
Ett eller flera tecken på blåsdysfunktion noterades hos 72.5% av barnen med CKD och 
hos lika många barn (72%) som hade genomgått en njurtransplantation. Tecken på 
blåsdysfunktion fanns hos alla barn (100%) som hade CKD till följd av urologiska 
sjukdomar, och hos 59% av de barn som hade CKD av icke-urologiska orsaker (p = 
0.0074). Förekomst av blåsdysfunktion hos barn som hade genomgått en 
njurtransplantation skiljde sig inte i grupperna urologiska/icke-urologiska sjukdomar 
(74% vs. 71%, NS). 47.5% av barnen med CKD hade en maximal blåsvolym som var 
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större än förväntat, vilket ofta var kombinerat med nedsatt uppfattning om blåsfyllnaden. 
Ett oregelbundet urinflödesmönster hittades hos 20% och residualurin hos 15 % av dessa 
barn. Motsvarande fynd hos njurtransplanterade barn var en stor blåsvolym hos 26%, ett 
avvikande urinflödesmönster hos 50% (hos 17.6% med tornformade urinflöden 
borträknade), och residualurin hos 32%. UVI var vanligare hos barn med CKD och 
tecken till blåsdysfunktion jämfört med barn utan blåsdysfunktion (55% vs. 0%, p = 
0.0012). Hos barn som hade genomgått en njurtransplantation, förekom UVI i samma 
utsträckning hos dem med och utan blåsdysfunktion (35% vs. 42%, NS). 
Återkommande UVIer var dock associerat med snabbare försämring av njurfunktionen 
jämfört med dem utan UVIer (p = 0.02). Barn med CKD och de som hade genomgått en 
njurtransplantation rapporterade likadana resultat i HRQoL-mätningarna när man 
jämförde grupper med eller utan blåsdysfunktion, men en subgrupp av barn med 
inkontinens rapporterade lägre välbefinnande. Signifikanta skillnader hittades hos 
flickor och äldre barn samt hos njurtransplanterade barn som skattade HRQoL lägre i 
jämförelse med pojkar, yngre barn respektive barn innan njurtransplantation. Hela 
gruppen (CKD+Tx) skattade sitt välbefinnande inom fysiska och psykologiska områden 
lägre än friska barn, men inga skillnader hittades i jämförelser med barn med andra 
kroniska sjukdomar. 
Sammanfattningsvis förekommer blåsdysfunktion ofta hos barn med CKD stadium 3–5 
och hos de som har genomgått en njurtransplantation. Blåsdysfunktion var vanlig inte 
bara hos barn med underliggande urologiska sjukdomar, utan även hos barn med icke-
urologiska sjukdomar. Tidigare UVIer var vanligare hos barn med CKD som hade 
blåsdysfunktion men efter njurtransplantation återfanns inte denna skillnad. Fynden i 
denna avhandling bidrar till vår kunskap vad gäller blåsfunktion hos barn med CKD 
stadium 3–5 och njurtransplanterade barn men bidrar även med kunskap om 
associationer mellan välbefinnandet i vardagslivet och blåsdysfunktion samt ytterligare 
aspekter såsom kön och ålder samt om barnet genomgått njurtransplantation eller ej. Det 
behövs dock ytterligare studier innan rekommendationer om eventuella interventioner 
kan ges.  
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